Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of aldose reductase in liver cancers may contribute to drug resistance

1 Feb 2001

Abstract excerpt

We previously found that about 29% of human liver cancers overexpressed aldose reductase (AR) and about 54% of them overexpressed an AR-like gene called ARL-1 that has similar enzymatic activities to AR. Since these aldo-keto reductases can reduce a broad spectrum of substrates including cytotoxic aldehydes, we were interested to find out if these enzymes can contribute to the resistance of liver cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aldose Reductase and Taurine
Share to Cannabis and Cannabinoid Research
Share to Prenatal Substance Exposure Effects

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11261885
DOI: 10.1097/00001813-200102000-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Overexpression of aldose reductase in liver cancers may contribute to drug resistancePMID 11261885Read ↗

Aldo–Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant CancersSemantic proximity Read ↗

The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistanceSemantic proximity Read ↗

The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cellsSemantic proximity Read ↗

Establishment and characterization of two 5-fluorouracil-resistant hepatocellular carcinoma cell linesSemantic proximity Read ↗

Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic AspectsSemantic proximity Read ↗

Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy ResistanceSemantic proximity Read ↗

ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory MechanismSemantic proximity Read ↗

Aldehyde Dehydrogenase, Liver Disease and CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.